Results 211 to 220 of about 291,386 (352)

Interpractice variability in antibiotic prescribing for acute respiratory tract infections: a cross-sectional study of Australian early-career general practitioners. [PDF]

open access: yesBMJ Open
Turner A   +14 more
europepmc   +1 more source

Asthma and Chronic Bronchitis [PDF]

open access: green, 1934
J. B. Christopherson
openalex   +1 more source

Dose‐Dependent Effects of Dietary n‐3 Fatty Acids on Bowel Health: Plant‐Sourced ALA Modulates Diarrhea Risk While Marine‐Sourced DHA/EPA Prevent Constipation in NHANES 2005–2010

open access: yesFood Science &Nutrition, Volume 13, Issue 8, August 2025.
This study revealed a nonlinear relationship between total n‐3PUFA intake and diarrhea risk, where moderate consumption (1.38–2.25 g/day) reduced odds by 30%, but excess (> 2.25 g/day) negates benefits. ALA drove 82.9% of this effect, exhibiting U‐shaped protection peaking at 1.29–2.23 g/day. Conversely, marine EPA/DHA linearly alleviated constipation (
Tingting Li, Yihui Shi, Lijun Cai
wiley   +1 more source

A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis

open access: yesEuropean Respiratory Journal, 2017
A. Dasgupta   +10 more
semanticscholar   +1 more source

Antineoplastic Effects of Thymoquinone on Pancreatic Atypical Acinar Cell Foci Treated With Azaserine

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 39, Issue 8, August 2025.
The main purpose of this study was to investigate the antioxidant and anticarcinogenic effects of TQ, which has many traditional uses and is naturally found in Nigella sativa seeds, on the neoplastic changes induced by azaserine in exocrine pancreatic acinar cells.
Hasan Yildiz, Başak Hartavi
wiley   +1 more source

Medical nutrition therapy in chronic obstructive pulmonary disease: A narrative review

open access: yesNutrition in Clinical Practice, Volume 40, Issue 4, Page 793-804, August 2025.
Abstract Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous lung condition characterized by persistent airflow obstruction, associated with cardiovascular, metabolic and musculoskeletal comorbidities. In 2022, approximately 480 million people were affected by this disease, making it the third leading cause of mortality ...
Patricia Savino‐Lloreda   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy